List of Excipients in API chlorhexidine gluconate 4%
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing chlorhexidine gluconate 4%
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Xttrium Laboratories Inc | BACTOSHIELD CHG | chlorhexidine gluconate 4% | 0116-0039 | COCO DIETHANOLAMIDE | |
| Xttrium Laboratories Inc | BACTOSHIELD CHG | chlorhexidine gluconate 4% | 0116-0039 | GLUCONOLACTONE | |
| Xttrium Laboratories Inc | BACTOSHIELD CHG | chlorhexidine gluconate 4% | 0116-0039 | HYDROXYETHYL CELLULOSE | |
| Xttrium Laboratories Inc | BACTOSHIELD CHG | chlorhexidine gluconate 4% | 0116-0039 | ISOPROPYL ALCOHOL | |
| Xttrium Laboratories Inc | BACTOSHIELD CHG | chlorhexidine gluconate 4% | 0116-0039 | LAURAMINE OXIDE | |
| Xttrium Laboratories Inc | BACTOSHIELD CHG | chlorhexidine gluconate 4% | 0116-0039 | PEG-75 LANOLIN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for chlorhexidine gluconate 4%
Excipient focus: COCO DIETHANOLAMIDE
chlorhexidine gluconate 4% drug variants containing COCO DIETHANOLAMIDE
chlorhexidine gluconate 4% drug variants not containing COCO DIETHANOLAMIDE
| Company | Ingredient | NDC |
|---|---|---|
| Xttrium Laboratories Inc | chlorhexidine gluconate 4% | 0116-0575 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
chlorhexidine gluconate 4% drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Xttrium Laboratories Inc | chlorhexidine gluconate 4% | 0116-0575 |
| >Company | >Ingredient | >NDC |
chlorhexidine gluconate 4% drug variants not containing FD&C RED NO. 40
Excipient focus: GLUCONOLACTONE
chlorhexidine gluconate 4% drug variants containing GLUCONOLACTONE
chlorhexidine gluconate 4% drug variants not containing GLUCONOLACTONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYETHYL CELLULOSE
chlorhexidine gluconate 4% drug variants containing HYDROXYETHYL CELLULOSE
chlorhexidine gluconate 4% drug variants not containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Xttrium Laboratories Inc | chlorhexidine gluconate 4% | 0116-0575 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
chlorhexidine gluconate 4% drug variants containing ISOPROPYL ALCOHOL
chlorhexidine gluconate 4% drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LAURAMINE OXIDE
chlorhexidine gluconate 4% drug variants containing LAURAMINE OXIDE
chlorhexidine gluconate 4% drug variants not containing LAURAMINE OXIDE
Excipient focus: PEG-75 LANOLIN
chlorhexidine gluconate 4% drug variants containing PEG-75 LANOLIN
chlorhexidine gluconate 4% drug variants not containing PEG-75 LANOLIN
| Company | Ingredient | NDC |
|---|---|---|
| Xttrium Laboratories Inc | chlorhexidine gluconate 4% | 0116-0575 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 237
chlorhexidine gluconate 4% drug variants containing POLOXAMER 237
| Company | Ingredient | NDC |
|---|---|---|
| Xttrium Laboratories Inc | chlorhexidine gluconate 4% | 0116-0575 |
| >Company | >Ingredient | >NDC |
chlorhexidine gluconate 4% drug variants not containing POLOXAMER 237
Excipient focus: TRIDECYL ALCOHOL
chlorhexidine gluconate 4% drug variants containing TRIDECYL ALCOHOL
chlorhexidine gluconate 4% drug variants not containing TRIDECYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Xttrium Laboratories Inc | chlorhexidine gluconate 4% | 0116-0575 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
chlorhexidine gluconate 4% drug variants containing WATER
chlorhexidine gluconate 4% drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
